key: cord-0707469-h2b582c8
authors: Virgo, Jonathan; Mohamed, Moin
title: Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection
date: 2020-07-03
journal: Eye (Lond)
DOI: 10.1038/s41433-020-1069-8
sha: fed5711134ec5f3cf4a9188dca50a42918f2a165
doc_id: 707469
cord_uid: h2b582c8

nan

Ophthalmic complications of COVID-19 are predicted based on prior knowledge of other coronaviruses [1] . Conjunctivitis can be the presenting sign/symptom and its presence correlates with severity [2] [3] [4] . Cotton wool spots and retinal microhaemorrhages have also been reported [5] . We report two patients who presented with a new paracentral scotoma following SARS-CoV-2 infection. Patient 1: A 37-year-old Caucasian female in week 14 of an uncomplicated pregnancy presented with a 1-day history of abrupt onset, faintly colourful, left eye paracentral scotoma. This was 35 days following the onset of a febrile illness with cough and anosmia. SARS-CoV-2 nasopharyngeal swab was not performed during the infection, but subsequently positive serology (IgG) has been confirmed. Past medical history included acephalgic visual migraine aura and right toxoplasma chorioretinitis. Examination showed normal visual acuity, no uveitis and fundoscopy was normal in the left eye. OCT changes correlated with the location of the scotoma (Fig. 1) . A focal area of hyper-reflective change in the inner and outer plexiform layers with inner nuclear layer volume loss was seen consistent with paracentral acute middle maculopathy (PAMM). Bloods were normal, including ESR, CRP, lipids, glucose, ANA and anti-phospholipid antibodies. An electrocardiogram and carotid Doppler ultrasound were normal. Patient 2: A 32-year-old Caucasian male presented with a 4-day history of abrupt onset, faintly colourful, right eye paracentral scotoma. This was 16 days following the onset of nasopharyngeal swab confirmed COVID-19. Past medical history included acephalgic visual migraine aura.

Examination showed normal visual acuity, no uveitis and fundoscopy was normal. Changes on infrared reflectance (white arrow) and OCT correlated with the location of the scotoma (Fig. 2) . A focal area of faint outer plexiform layer hyper-reflective change (black arrow) and disruption of the interdigitation zone (white box) were seen consistent with acute macular neuroretinopathy (AMN).

These patients developed PAMM and AMN soon after confirmed SARS-CoV-2 infection and possibly represent postinfectious complications. COVID-19 has been reported in association with acute limb ischaemia, stroke and the so called "paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection" [6] [7] [8] . PAMM and AMN have similar underlying pathophysiology.

PAMM was first described as a variant of AMN [9] , but they are now regarded as distinct conditions with overlapping features. PAMM OCT changes are seen in various retinal vascular diseases, such as retinal vein and artery occlusion. OCT angiography (OCT-A) has provided further support for a retinal vascular aetiology in PAMM and AMN [10] [11] [12] [13] [14] [15] . Projection resolved OCT-A distinguishes the intermediate from the deep capillary plexus, which run either side of the inner nuclear layer. Using this technique, it has been shown that PAMM occurs in association with reduced flow in the intermediate, deep and occasionally the superficial capillary plexuses, whereas AMN occurs in association with reduced flow in the deep capillary plexus [15] . Finally, in a series of Fig. 1 Optical coherence tomography image from patient 1. Focal area of hyper-reflective change in the inner and outer plexiform layers with inner nuclear layer volume loss consistent with paracentral acute middle maculopathy. [16] . This is the first report of PAMM/AMN following COVID-19. A larger case series is needed to determine if there is a true association.

Conflict of interest The authors declare that they have no conflict of interest.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Fig. 2 Infrared reflectance and optical coherence tomography images from patient 2. Focal area of IR change (white arrow) due to faint outer plexiform layer hyper-reflective change (black arrow) and disruption of the interdigitation zone (white box) on OCT consistent with acute macular neuroretinopathy.

Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals

Conjunctivitis can be the only presenting sign and symptom of COVID-19

Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19

Conjunctivitis and COVID-19: a meta-analysis

Retinal findings in patients with COVID-19

Acute limb ischemia in patients with COVID-19 pneumonia

Large-vessel stroke as a presenting feature of Covid-19 in the young

European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children

Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia

Optical coherence tomography angiography of acute macular neuroretinopathy and paracentral acute middle maculopathy

Paracentral acute middle maculopathy: what we knew then and what we know now

Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography

Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: a quantitative optical coherence tomography angiography study. Retina Cases Brief Rep

Projectionresolved OCT angiography of microvascular changes in paracentral acute middle maculopathy and acute macular neuroretinopathy

Microvascular change in acute macular neuroretinopathy by using optical coherence tomography angiography

Acute macular neuroretinopathy: a comprehensive review of the literature